Due to a technical problem, the SmallCap Informer website was not accessible when the issue was released, so the issue was emailed directly to all subscribers. The website is operational once again, so the issue and accompanying Toolkit 6 stock studies are now available in the Subscriber's area.

In this issue of the SmallCap Informer, you’ll find two new stock selections for your review. Our first company pick is a healthcare company involved in the treatment of substance-abuse and behavior disorders. Our second focus stock is a biotechnology company that’s developing and producing a treatment for an affliction that affects millions around the world.